LifeMD vs Hims Weight Loss 2026

LifeMD vs Hims Weight Loss: Two Publicly Traded GLP-1 Platforms Compared (2026)

Medically reviewed by Telehealth Ally Medical Review Team. Pricing and protocol data last verified April 2026.

LifeMD (NASDAQ: LFMD) and Hims & Hers (NYSE: HIMS) are the two publicly traded GLP-1 telehealth platforms — SEC-audited financials, brand-name medications, and DTC scale on both sides. The similarity ends there.

LifeMD holds direct commercial agreements with Novo Nordisk and Eli Lilly, accepts most PPO insurance plans, and handles prior authorization in-house. Hims offers an efficient async-only experience at a lower entry price — though as of April 2026, it has also exited compounding for semaglutide following the Novo Nordisk settlement.

The decision between them turns almost entirely on whether you have PPO insurance that covers GLP-1 medications.

Quick verdict: LifeMD vs Hims

Choose LifeMD if: You have PPO insurance that covers Wegovy or Zepbound, or you want direct manufacturer access to the broadest branded GLP-1 menu in telehealth. LifeMD's prior authorization handling alone can save patients hours of insurer back-and-forth.

Choose Hims if: You're an existing Hims customer, you're self-pay and want a familiar DTC brand, or you want an efficient async-only experience without a separate program fee.

	LifeMD	Hims
All-in entry price (self-pay)	~$224/mo (orforglipron, pending approval)	~$199/mo (compounded semaglutide, subject to change)
Insured all-in (PPO)	~$29/mo program fee + medication copay	Not offered
Consultation model	Video (within 1 hr) + async	Async-only
Insurance accepted	✅ Most PPO plans	❌
Prior authorization handled	✅ In-house	❌
Brand Wegovy (injectable)	✅ Direct Novo Nordisk partnership	✅ Via insurance or authorized distributor
Wegovy pill (oral semaglutide)	✅ Multiple dose tiers	❌
Wegovy HD (7.2mg)	✅ Available April 2026	❌
Zepbound (tirzepatide)	✅ $349–499/mo via LillyDirect	✅ $399/mo
Orforglipron (pending FDA approval)	✅ $149/mo via LillyDirect	❌
Compounded GLP-1	❌ No longer offered	❌ Exited April 2026
Lab work included	✅ Labcorp/Quest partnerships	❌
Non-GLP-1 weight management	✅ Triple Therapy ($129/mo)	❌
50-state availability	✅	Varies by state

How does LifeMD work for weight loss?

LifeMD's program is built around its manufacturer partnerships. It holds direct commercial agreements with Novo Nordisk (Wegovy) and Eli Lilly (Zepbound, orforglipron), which allows it to write prescriptions for finished, FDA-approved medications at negotiated prices — not compounded formulations from 503B outsourcers.

1. Online intake — Medical questionnaire covering health history, BMI, current medications, and weight loss goals. The intake screens for GLP-1 contraindications including personal or family history of medullary thyroid carcinoma and MEN 2 syndrome.
2. Provider consultation — Video consultations available within 1 hour. Async review typically returned within 4 hours. Patients choose which they prefer.
3. Treatment plan — Medications either ship directly or route through LillyDirect (for Zepbound and orforglipron).
4. Insurance navigation — For PPO patients, LifeMD's care coordination team submits prior authorization paperwork, handles appeals, and manages insurer communication. Compounded medications are not covered by insurance; LifeMD's brand-name access is what makes insurance relevant here.
5. Ongoing care — 24/7 provider messaging; video visits at $50/session as needed. "6S" wellness check-ins covering sleep, stress, substance use, and other lifestyle factors. Lab monitoring through Labcorp and Quest at no additional cost.

LifeMD no longer offers compounded semaglutide or tirzepatide — the entire program runs on manufacturer-approved branded medications.

How does Hims work for weight loss?

Hims' weight loss program runs on an async-only model. There are no video consultations — a licensed provider reviews your intake questionnaire and responds within 24 hours. The experience is designed for speed and efficiency, not clinical depth.

1. Online intake — Medical questionnaire covering health history, current medications, BMI, and weight goals. Screens for contraindications.
2. Async provider review — A licensed provider evaluates your submission. Most patients hear back within 24 hours.
3. Prescription and shipping — Medication ships free within 3–5 business days.
4. Ongoing support — Unlimited provider messaging for dose adjustments and questions. No scheduled follow-ups.

As of April 2026, Hims exited compounding for semaglutide following the Novo Nordisk settlement and is operating as an authorized brand distributor. Current pricing should be verified at hims.com before enrolling.

Pricing last verified April 2026. We update pricing data monthly.

How do LifeMD and Hims compare on price?

Pricing is the sharpest dividing line between these two platforms — and it depends heavily on whether you have insurance.

	LifeMD	Hims
Program/subscription fee	$75/mo (standard) or $29/mo (insured)	None
Compounded semaglutide	❌ Not offered	Subject to change — verify at hims.com
Orforglipron (pending approval)	$149/mo + $75/mo fee = ~$224/mo total	❌ Not offered
Oral Wegovy (4mg)	$199/mo + fee = ~$274/mo total	❌ Not offered
Brand Wegovy (injectable)	$499/mo + fee = ~$574/mo self-pay; ~$29/mo + copay insured	Insurance-dependent
Brand Zepbound	$349–499/mo + fee = $424–$574/mo total	$399/mo
Lab work	Included	Not offered
Video consultations	$50/session	Not offered

For uninsured patients: LifeMD is more expensive than Hims for most comparable pathways. If orforglipron receives FDA approval on April 10, 2026, LifeMD's $224/mo all-in path would be competitive with compounded pricing at other platforms, but with a brand-name product and no compounding risk. Hims' pricing on brand-name medications should be verified directly — it has shifted following the semaglutide compounding exit.

For insured patients: LifeMD's advantage is significant. The program fee drops to $29/mo for patients with qualifying PPO coverage, and Wegovy or Zepbound may cost $0–$75/mo at copay. Hims does not accept insurance, so for insured patients the choice is straightforward: LifeMD handles the coverage; Hims doesn't.

Does LifeMD or Hims accept insurance?

LifeMD accepts most major PPO plans. Hims does not accept insurance for weight loss medications.

LifeMD's insurance process:

• Accepts most major PPO insurance plans
• Handles prior authorization in-house — submits paperwork, coordinates appeals, manages insurer back-and-forth
• Program fee drops to $29/mo for qualifying insured patients
• Brand Wegovy may cost $0/mo with a qualifying plan
• Does not accept Medicare or Medicaid for the GLP-1 weight loss program

Hims and insurance:

• Assists with prior authorization for brand Wegovy, but this is primarily patient-driven
• No insurance-integrated program fee structure
• All cash-pay for the standard program

For patients with employer PPO coverage that includes Wegovy or Zepbound, LifeMD's insurance infrastructure can reduce all-in costs below what any cash-pay platform charges. If your plan covers GLP-1 medications and you can navigate a prior authorization, LifeMD is the operationally strongest option in telehealth for making that coverage work.

Which medications does each platform offer?

Medication	LifeMD	Hims
Compounded semaglutide	❌ No longer offered	❌ Exited April 2026
Brand Wegovy (injectable, 2.4mg)	✅ Novo Nordisk partnership	✅ Via insurance/authorized distributor
Brand Wegovy HD (7.2mg)	✅ Expected April 2026	❌
Wegovy pill (oral, 4mg)	✅	❌
Wegovy pill (oral, 9–25mg)	✅	❌
Brand Zepbound (tirzepatide)	✅ LillyDirect	✅ $399/mo
Orforglipron (pending approval)	✅ $149/mo via LillyDirect	❌
Ozempic (off-label)	✅	❌
Saxenda (liraglutide)	✅	❌
Triple Therapy (metformin + bupropion + topiramate)	✅ $129/mo	❌

LifeMD's breadth is substantial. The oral Wegovy lineup (multiple dose tiers), the expected Wegovy HD path following the March 19, 2026 approval, and the orforglipron launch (pending April 10 PDUFA) give LifeMD a branded medication menu that no other telehealth platform currently matches. The non-GLP-1 Triple Therapy option at $129/mo also serves patients who don't qualify for or don't respond to GLP-1 medications.

Hims' medication menu has narrowed following the semaglutide compounding exit. What they offer in terms of brand-name branded coverage is relevant but more limited. Verify current Hims GLP-1 options at hims.com before enrolling — the lineup has changed and may continue to shift.

Orforglipron note: Eli Lilly's oral GLP-1 pill has a PDUFA date of April 10, 2026. If approved, LifeMD has announced $149/mo pricing via its LillyDirect partnership. This would represent the most affordable brand-name GLP-1 in telehealth. Hims has not announced an orforglipron pathway.

Who is LifeMD best for?

• Patients with PPO insurance that covers Wegovy or Zepbound — LifeMD handles prior authorization and reduces the program fee to $29/mo
• Those who want the broadest branded GLP-1 menu: oral Wegovy, Wegovy HD, Zepbound, and orforglipron on a single platform
• Patients who want video consultations with same-day availability and lab monitoring included
• People who want brand-name, FDA-approved medications without compounding risk
• Patients interested in the Wegovy pill as an injection-free branded option

Read our full LifeMD weight loss review for complete pricing tables, how the insurance navigation works, and who the program serves best.

Who is Hims best for?

• Existing Hims customers who already use the platform for other health services (sexual health, dermatology, mental health)
• Self-pay patients who want an efficient, no-frills async experience
• Patients comfortable with a simpler branded GLP-1 path through an established DTC brand
• Those who don't have insurance covering GLP-1s and want a familiar, large-scale telehealth provider

Read our full Hims weight loss review for full details on Hims' current GLP-1 offerings, pricing, and how it compares to other budget options.

Also see: Hims vs Ro weight loss — if you're comparing Hims to other budget async platforms — and Ro vs Calibrate for how the budget end of the market contrasts with comprehensive programs.

Frequently Asked Questions

Is LifeMD or Hims cheaper for weight loss? For self-pay patients, Hims' current pricing should be verified directly — it has shifted following the April 2026 semaglutide compounding exit. LifeMD's entry path (orforglipron, pending FDA approval) would be ~$224/mo all-in. For insured patients with PPO coverage, LifeMD is meaningfully cheaper: the program fee drops to $29/mo and medication may cost $0–$75/mo copay. Hims does not accept insurance.

Does LifeMD accept insurance for weight loss? Yes. LifeMD accepts most major PPO insurance plans and handles prior authorization in-house. Medicare and Medicaid are not accepted for the GLP-1 weight loss program. The program fee for qualifying insured patients is $29/mo. Brand Wegovy through insurance may cost $0/mo depending on your plan.

Does Hims accept insurance for weight loss? No. Hims does not accept insurance for weight loss medications. The program is cash-pay only. Hims assists with prior authorization paperwork for brand Wegovy, but this is not integrated into a reduced-fee program structure the way LifeMD's is.

Which platform has the better medication selection? LifeMD. It holds direct commercial agreements with Novo Nordisk and Eli Lilly and offers Wegovy (multiple doses and formulations), Zepbound, orforglipron (pending approval), and non-GLP-1 alternatives. Hims' GLP-1 menu has narrowed since the April 2026 compounding exit.

Do either LifeMD or Hims still offer compounded semaglutide? No. LifeMD no longer offers compounded GLP-1 medications and has transitioned fully to brand-name products via manufacturer partnerships. Hims exited semaglutide compounding following the April 2026 Novo Nordisk settlement and is now operating as an authorized brand distributor. Both changes reflect ongoing FDA enforcement actions that have largely wound down the compounded GLP-1 market.

Can I use LifeMD if I'm on Medicare? No. LifeMD does not accept Medicare or Medicaid for the GLP-1 weight loss program. Medicare patients seeking GLP-1 access should look at platforms that support the Medicare GLP-1 Bridge Program.

Related Comparisons

• Hims vs Ro weight loss — Comparing the two large async-only budget platforms
• Ro vs Calibrate 2026 — How the budget market compares to a comprehensive program
• LifeMD weight loss review — Full review with pricing, insurance details, and clinical depth assessment
• Hims weight loss review — Full review of Hims' GLP-1 program
• LifeMD vs Ro Weight Loss — How LifeMD compares to another major platform

Data Sources & Methodology

Pricing and protocol data sourced from LifeMD and Hims & Hers public websites and verified via checkout flow, April 2026. Hims pricing reflects the April 2026 semaglutide compounding exit; verify current offerings at hims.com before enrolling. LifeMD revenue data from public SEC filings. Telehealth Ally has no commercial relationship with either provider. Rankings and ratings are editorial-only.